Join us on Wednesday, September 10 for a webinar with surgeon-scientist Vinod Balachandran, M.D., founding director of the Olayan Center for Cancer Vaccines Memorial Sloan Kettering Cancer Center. Dr. Balachandran will talk about how his research is making headway into promising avenues for treating people with pancreatic cancer and other difficult-to-treat diseases. https://go.nih.gov/wJ06HjH #CancerResearch #CancerImmunotherapy
NCI Division of Cancer Prevention
Research Services
Rockville, Maryland 8,437 followers
Conducting and supporting research to prevent cancer and its consequences.
About us
The Division of Cancer Prevention (DCP) is the division of the National Cancer Institute (NCI) devoted to cancer prevention research. DCP supports research on cancer prevention, interception, screening and early detection, and symptom science. To accomplish this, DCP provides funding and administrative support to clinical, population science, and laboratory researchers, community and multidisciplinary teams, and collaborative scientific networks. NCI is part of the National Institutes of Health within the U.S. Department of Health and Human Services. NCI Privacy Policy: https://www.cancer.gov/policies/privacy-security
- Website
-
https://prevention.cancer.gov/
External link for NCI Division of Cancer Prevention
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Rockville, Maryland
- Specialties
- cancer prevention, population science, cancer research , cancer screening, grants, funding, and cancer interception
Updates
-
Join us for the next Building Bridges in Cancer Symptom Science webinar on Friday, September 12. Heather Jim, Ph.D., from Moffitt Cancer Center and Susan Watters Wesmiller, Ph.D., RN, FAAN, from the University of Pittsburgh will talk about research and strategies for mitigating cancer-treatment induced nausea and vomiting. Register now! https://go.nih.gov/HzmMvRT #CancerSymptomScience #CancerResearch
-
-
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), created an evaluation framework to select multi-cancer detection (MCD) assays for the Vanguard Study. Read the original research article in the August issue of Cancer Epidemiology, Biomarkers & Prevention (CEBP): https://lnkd.in/eyzQskKY NCI authors from the Division of Cancer Prevention: Elyse LeeVan, MD, M.P.H., Amanda Skarlupka, PhD, MS, Christos Patriotis, Ph.D., M.Sc., Wendy Rubinstein, MD, PhD., Paul F. Pinsky, Ph.D., Daniel Edelman Ph.D., Erin Lavik, ScD., Mary Jane Ong, B.S.N., M.S., and Philip Prorok, Ph.D. #MCDtests #CancerResearch #Cancerscreening #CancerPrevention
-
-
The NCI Cancer Prevention Fellowship Program (CPFP) application period closes next month! https://lnkd.in/e3-Qxm5W The CPFP empowers postdoctoral fellows to become leading scientists in domestic and global prevention research through a program of comprehensive scientific training, collaborative research opportunities, and professional partnerships. If you know a researcher with interests in the field of cancer prevention and related areas, share this opportunity with them. Applications for the 2026 cohort will be accepted through September 12, 2025.
-
-
Join us for the next Building Bridges in Cancer Symptom Science webinar on Wednesday July 30. Joerg Herrmann, M.D., and Kathryn Ruddy, M.D., M.P.H. from the Mayo Clinic Comprehensive Cancer Center will talk about current research on evaluating and managing cancer treatment-related cardiotoxicities. Register now! https://go.nih.gov/gtwTmlt #CancerSymptomScience #CancerResearch #cardiotoxicity
-
-
NCI is pleased to support the Cancer Screening Research Network (CSRN) Vanguard Study. This pilot study is an important step towards understanding how multi-cancer detection (MCD) tests perform in real-world settings. #MCD tests #CancerResearch #Cancerscreening #CancerPrevention
Fred Hutch Cancer Center is leading the newly launched Vanguard Study, a national study of a new type of blood test that screens for several different cancers called multi-cancer detection (MCD) tests. Researchers will evaluate whether these blood tests will help people ages 45 to 75 find cancer early when it may be easier to treat. This is the first study of the Cancer Screening Research Network (CSRN), a nationwide network that will run trials aimed at improving cancer screening that is funded by the National Cancer Institute (NCI), part of the National Institutes of Health. Fred Hutch serves as the Coordinating and Communications Center as well as the Statistics and Data Management Center. https://bit.ly/4lTKpPV
-
✍ Mark your calendar: Bhardwaj Nina, M.D., Ph.D., director of immunotherapy and medical director of the Vaccine and Cell Therapy Core facility at the Icahn School of Medicine at Mount Sinai, will give a talk on Lynch syndrome as part of the NCI DCP Immunology Interest Group Seminar Series. Register now! https://lnkd.in/gB-Nzwzy
-
-
Join us for the last two talks of the 2025 DCP Early Career Scientist Spotlight Research Seminar Series. On June 16 Dr. Mary Luz RoL will give a talk on “Advancing AI-Driven Systems for Cervical Cancer Screening, Triage, and Treatment.” And on July 10 Dr. Mina Sedrak will present “Targeting Aging Biology to Optimize the Long-Term Health of Cancer Survivors.” Register for both today: https://lnkd.in/gxZHQ5Hw
-
-
✍ Mark your calendar: Bhardwaj Nina, M.D., Ph.D., director of immunotherapy and medical director of the Vaccine and Cell Therapy Core facility at the Icahn School of Medicine at Mount Sinai, will give a talk on Lynch syndrome as part of the NCI DCP Immunology Interest Group Seminar Series. Register now! https://lnkd.in/gB-Nzwzy
-
-
Join us June 11 at noon ET for an invited talk by Amy Moran, Ph.D., from the Oregon Health & Science University. Dr. Moran will present “Uncovering Hormone Mediated Mechanisms of Sex Differences in Cancer.” Register today: https://lnkd.in/eWJ-Yt6R
-